Aquaculture disease control is moving from reactive treatment toward continuous, data-driven prevention. A new review describes how artificial intelligence, biosensors, molecular diagnostics, nanotechnology and genome-based vaccines could increasingly work together to detect disease earlier, predict outbreaks and reduce dependence on antibiotics, although cost, data quality and access remain major barriers to widespread adoption.
The review examines the evolution of fish disease diagnosis and management, from conventional microscopy and culture to PCR, next-generation sequencing, point-of-care diagnostics, AI-assisted image analysis and intelligent aquaculture systems.
AI is moving diagnosis closer to the farm
One of the most immediate applications is automated image analysis. Machine-learning systems can identify abnormal coloration, fin erosion, skin lesions and gill abnormalities from images of fish. The review cites convolutional neural-network studies reporting diagnostic accuracies around 90–94% in selected datasets. Smartphone-based systems could eventually allow farmers to photograph lesions and obtain rapid preliminary assessments without immediate access to a laboratory.
But image recognition is only one component. AI can also analyse swimming behaviour, feeding patterns and activity, looking for deviations that may precede obvious clinical signs. In some experimental settings, group swimming behaviour has predicted gill disease in salmon with accuracy above 90%.
These systems should not be interpreted as replacements for veterinary diagnosis. Their value lies primarily in early warning and triage, identifying populations that require closer examination or laboratory testing.
Biosensors could make disease surveillance continuous
The review places particular emphasis on combining AI with biosensors. Electrochemical sensors, molecular biosensors and wearable devices can measure pathogen biomarkers, stress indicators or environmental parameters and feed these data into machine-learning models. This creates the possibility of monitoring fish populations continuously rather than sampling only when mortality or clinical disease becomes visible. Environmental surveillance is important in aquaculture because temperature, pH, oxygen, salinity and water quality can directly influence both pathogen multiplication and host susceptibility.
AI systems integrating these variables with historical disease data can generate outbreak-risk alerts, potentially allowing farmers to modify water conditions, increase surveillance or reinforce biosecurity before a disease episode becomes severe.
But predictive models are only as reliable as the data used to train them. Standardisation, external validation and representative datasets remain essential.
Nanotechnology opens new options for treatment and vaccination
Nanotechnology represents another major area of development. Nanoparticles are being explored for drug delivery, vaccine delivery, water treatment, pathogen detection and environmental remediation. Biodegradable materials such as alginate, chitosan, PLGA and liposomes can encapsulate vaccines, drugs or immunostimulants and potentially deliver them through feed rather than individual injection. For large fish populations, oral delivery would have obvious practical advantages.
However, many nanotechnology applications remain experimental, and efficacy, environmental fate, toxicity and regulatory requirements will need careful evaluation before routine commercial use.
Genomics could accelerate vaccine development
The review also highlights reverse vaccinology, which starts with pathogen genome sequences rather than traditional antigen screening. Bioinformatic analysis can identify conserved proteins likely to be exposed to the immune system and therefore potential vaccine targets. This approach is particularly attractive for pathogens that have proved difficult to control with conventional vaccine-development methods. In aquaculture, however, the authors note that reverse vaccinology remains much less developed than in human medicine.
The availability of genomic and transcriptomic data for pathogens such as sea lice nevertheless provides a foundation for future work.
Reducing antibiotic dependence is a central objective
The technological transition described in the review has an important One Health dimension. Aquaculture disease management has traditionally relied heavily on antimicrobial treatment in some production systems, creating concerns over residues and antimicrobial resistance. The authors see vaccines, probiotics, prebiotics, immunostimulants, medicinal plants, precision diagnostics and targeted treatment as part of a broader shift toward preventive disease management and lower antibiotic use.
Earlier and more precise diagnosis should also reduce empirical treatment, one of the pathways by which unnecessary antimicrobial use can occur.
The technological divide remains a major obstacle
The review is also clear that “smart aquaculture” will not automatically be accessible to every producer. Advanced molecular diagnostics, sensors, sequencing platforms and AI infrastructure require investment, technical expertise and reliable digital connectivity. These constraints are particularly important for small-scale producers and farms in lower-resource settings.
Climate change adds another layer of complexity by altering water temperatures, ecosystems and disease patterns.
The future of fish health management therefore depends not only on developing better technology, but on making it affordable, validated and usable in real production environments.
Commentaires
No comments yet.
Sign in to comment